Factor VIII is a positive regulator of platelet function

FVIII is an important cofactor in the tenase coagulation factor complex, lack of FVIII causes severe bleeding, whereas high FVIII levels seem to be associated with venous and arterial thromboembolism. Resting platelets do not bind FVIII, but activated platelets bind unactivated FVIII if vWF is not present. We investigated a possible influence of platelet bound FVIII on platelet function itself as it is unclear if there is a direct effect of FVIII on platelet function. The influence of FVIII on platelet function was investigated by flow cytometric analysis of P-selectin expression (CD62P) and PAC-1 binding before and after submaximal stimulation with TRAP-6 (5 µM final concentration), by confocal microscopy and by platelet aggregometry. For flow cytometry and confocal microscopy, washed platelets were incubated with human recombinant FVIII for 5 min at 37°C. Analysis of platelet surface area was measured by computerized image analysis. Treatment with FVIII only caused no changes in P-selectin expression or PAC-1 binding, respectively. Stimulation of platelets with TRAP-6 increased the expression of P-selectin (445%) and PAC-1 binding (934%) as expected. These effects were further increased when platelets were stimulated with TRAP-6 and FVIII (P-selectin 499%, difference not significant; PAC-1 1626%, P < 0.05. Values were expressed in%, related to unstimulated, buffer treated platelets). Platelet spreading on fibrinogen was significantly increased when platelets were treated with FVIII and TRAP-6 compared to TRAP-6 alone (368 vs. 307 average pixel/platelet, P<0.05). In addition platelet aggregation was enhanced when platelets were stimulated with FVIII and TRAP-6 compared to TRAP-6 alone. FVIII can act as a positive regulator of platelet function in TRAP-co-stimulated platelets. We hypothesize that FVIII induced increase in platelet activation might contribute to venous and even arterial thrombus formation in patients with high FVIII levels.

[1]  M. Prins,et al.  Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis , 2005, Journal of thrombosis and haemostasis : JTH.

[2]  S. Lord,et al.  Fibrin stimulates platelets to increase factor VIIIa binding site expression , 2004, Journal of thrombosis and haemostasis : JTH.

[3]  Mario Berger,et al.  High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII , 2004, Thrombosis and Haemostasis.

[4]  A. Mócsai,et al.  Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton , 2002, The Journal of cell biology.

[5]  J. Freedman,et al.  Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C) , 2002, American journal of hematology.

[6]  D. Monroe,et al.  A Cell-based Model of Hemostasis , 2001, Thrombosis and Haemostasis.

[7]  Joseph M. Scandura,et al.  Structural and Functional Characterization of Platelet Receptor-mediated Factor VIII Binding* , 2000, The Journal of Biological Chemistry.

[8]  E. Saenko,et al.  Activation of Factor VIII by Thrombin Increases Its Affinity for Binding to Synthetic Phospholipid Membranes and Activated Platelets* , 1998, The Journal of Biological Chemistry.

[9]  S. Shattil,et al.  Integrin signaling: the platelet paradigm. , 1998, Blood.

[10]  V. Blanchette,et al.  Platelet activation induced by porcine factor VIII (HYATE:C) , 1998, American journal of hematology.

[11]  D. Gabriel,et al.  The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding. , 1997, Biochemistry.

[12]  J. Barrett,et al.  von Willebrand Factor and Factor VIII: C in Acute Cerebrovascular Disease , 1997, Thrombosis and Haemostasis.

[13]  B. Furie,et al.  Platelet-derived microparticles express high affinity receptors for factor VIII. , 1991, The Journal of biological chemistry.